Versigent Q2 FY26 net income rises 10.3% to $118 million; net sales increase 10.8% to $2.44 billion

• Versigent Q2 2026 net sales rose 10.8% to $2.44 billion; net income attributable to shareholders increased 10.3% to $118 million.
• Diluted EPS climbed to $1.64; interest expense widened to $36 million from $1 million a year earlier.
• Free cash flow held at $107 million; operating cash flow edged up to $158 million from $150 million.
• Board declared an inaugural quarterly dividend of $0.13 per share, payable Sept. 18 to holders of record Sept. 4.
• Lifted full-year net sales outlook to $9.4 billion-$9.6 billion from $9.1 billion-$9.4 billion; reaffirmed adjusted EBITDA of $950 million-$1.03 billion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Versigent plc published the original content used to generate this news brief via Business Wire (Ref. ID: 202608040645BIZWIRE_USPR_____20260804_BW545127) on August 04, 2026, and is solely responsible for the information contained therein.